TABLE 4.
Dose ratios of 2-BFI alone, opioids alone, and 2-BFI+opioid mixtures to produce antinociception versus suppression of operant responding
Mechanical | Thermal | |
---|---|---|
2-BFI alone | 1.39 | 0.99 |
Fentanyl alone | 4.00* | 2.00* |
1:3 2-BFI/fentanyl | 4.63a,* | 1.55* |
1:1 2-BFI/fentanyl | 2.07* | 0.80 |
3:1 2-BFI/fentanyl | 2.06* | 0.93 |
Buprenorphine alone | <0.43 | 10.00 |
1:3 2-BFI/buprenorphine | 3.71a,* | 1.47* |
1:1 2-BFI/buprenorphine | 3.96a,* | 0.85 |
3:1 2-BFI/buprenorphine | 1.07 | 0.66 |
NAQ alone | <0.35 | <0.35 |
1:3 2-BFI/NAQ | 2.17a,* | 0.80 |
1:1 2-BFI/NAQ | 3.46a,* | 1.05a |
3:1 2-BFI/NAQ | 1.57a | 0.85 |
Dose ratio for a combination is greater than dose ratio for either component drug.
Drug or drug mixture was significantly more potent in the assay of nociception as determined by nonoverlapping confidence limits of Zmix values.